FLOT1 and metastatic prostate carcinoma: Consistent with the results shown in Fig. 2c and Supplementary Fig. S1a, there was no significant difference of FLOT1 (Flot-1) expression among benign and primary and metastatic prostate cancer tissues (Fig. 6d).